Abstract
Aim: The aim of the study was to assess the factors that influence carotid intima-media thickness (CIMT) and arterial stiffness in type 1 diabetic patients.
Material and Methods: We included 87 type 1 diabetic patients (44 women, 43 men), median age 34 years, disease duration 10 years, HbA1c 8.2%. CIMT was measured using high resolution ultrasonography. Arterial stiffness was assessed with the use of digital volume pulse analysis and tonometric measurement of wave reflection and central haemodynamics. Serum C-reactive protein (hsCRP), matrix metalloproteinase-9 (MMP-9), soluble intracellular adhesion molecule-1 (sICAM-1) and myeloperoxidase (MPO) concentrations were also measured.
Results: CIMT and arterial stiffness correlated with age, duration of diabetes, systolic and diastolic blood pressure, GFR-glomerular filtration rate and sICAM-1. Multiple regression analysis identified only age as significant determinant of CIMT. Age, mean blood pressure and GFR, but not duration of diabetes were significant determinants of arterial stiffness.
Conclusions: In type 1 diabetic patients both CIMT and arterial stiffness were related to age, blood pressure, kidney function and sICAM-1 serum concentration.
Key words
type 1 diabetes - carotid intima-media thickness - arterial stiffness - sICAM-1
References
-
1
Berry KL, Skyrme-Jones RA, Cameron JD. et al .
Systemic arterial compliance is reduced in young patients with IDDM.
Am J Physiol.
1999;
276
((6))
1839-1845
-
2
Bulpitt CJ, Cameron JD, Rajkumar C. et al .
The effect of age on vascular compliance in man: which are the appropriate measures?.
J Hum Hypertens.
1999;
13
((11))
753-758
-
3
Cheng HM, Ye ZX, Chiou KR. et al .
Vascular stiffness in familial hypercholesterolaemia is associated with C-reactive protein and cholesterol burden.
Eur J Clin Invest.
2007;
37
((3))
197-206
-
4
Coccheri S.
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
Drugs.
2007;
67
((7))
997-1026
-
5
Cohn JN, Quyyumi AA, Hollenberg NK. et al .
Surrogate markers for cardiovascular disease: functional markers.
Circulation.
2004;
109
((25))
31-46
-
6
Devaraj S, Dasu MR, Jialal I.
Diabetes is a proinflammatory state: a translational perspective.
Expert Rev Endocrinol Metab.
2010;
5
((1))
19-28
-
7
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
.
Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications.
Diabetes.
1999;
48
((2))
383-390
-
8
Gul K, Ustun I, Aydin Y. et al .
Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus.
Anadolu Kardiyol Derg.
2010;
10
52-58
-
9
Jensen-Urstad KJ, Reichard PG, Rosfors JS. et al .
Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM.
Diabetes.
1996;
45
((9))
1253-1258
-
10
Kampus P, Kals J, Ristimae T. et al .
Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein.
J Hypertens.
2007;
25
((4))
819-825
-
11
Kannel WB, McGee DL.
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study.
Diabetes Care.
1979;
2
((2))
120-126
-
12
Karamitsos TD, Karvounis HI, Didangellos TP. et al .
Usefulness of colour tissue Doppler imaging in assessing aortic elastic properties in Type 1 diabetic patients.
Diabet Med.
2006;
23
((11))
1201-1206
-
13
Kim JS, Kang TS, Kim JB. et al .
Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients.
Atherosclerosis.
2007;
192
((2))
401-406
-
14
Knudsen ST, Poulsen PL, Hansen KW. et al .
Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes.
Am J Hypertens.
2002;
15
((3))
244-250
-
15
Koivisto VA, Stevens LK, Mattock M. et al .
Cardiovascular disease and its risk factors in IDDM in Europe EURODIAB IDDM Complications Study Group.
Diabetes Care.
1996;
19
((7))
689-697
-
16
Larsen JR, Brekke M, Bergengen L. et al .
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes.
Diabetologia.
2005;
48
((4))
776-779
-
17
Lawson C, Wolf S.
ICAM-1 signaling in endothelial cells.
Pharmacol Rep.
2009;
61
((1))
22-32
-
18
Nagano M, Nakamura M, Sato K. et al .
Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population.
Atherosclerosis.
2005;
180
((1))
189-195
-
19
Nathan DM, Lachin J, Cleary P. et al .
Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group. Intensive Diabetes Therapy and Carotid Intima-Media Thickness in Type 1 Diabetes Mellitus.
N Engl J Med.
2003;
348
((23))
2294-2303
-
20
Ogawa Y, Uchigata Y, Iwamoto Y.
Progression Factors of Carotid Intima-Media Thickness and Plaque In Patients with Long-Term, Early-Onset Type 1 Diabetes Mellitus In Japan: Simultaneous Comparison with Diabetic Retinopathy.
J Atheroscler Thromb.
2009;
16
((6))
821-828
-
21
Oliver JJ, Webb DJ.
Noninvasive assessment of arterial stiffness and risk of atherosclerotic events.
Arterioscler Thromb Vasc Biol.
2003;
23
((4))
554-566
-
22
Orchard TJ, Olson JC, Erbey JR. et al .
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Diabetes Care.
2003;
26
((5))
1374-1379
-
23
Payne RA, Wilkinson IB, Webb DJ.
Arterial stiffness and hypertension: emerging concepts.
Hypertension.
2010;
55
((1))
9-14
-
24
Pujia A, Gnasso A, Irace C. et al .
Common carotid arterial wall thickness in NIDDM subjects.
Diabetes Care.
1994;
17
((11))
1330-1336
-
25
Reasner CA.
Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
J Cardiovasc Pharmacol.
2008;
52
((2))
136-144
-
26
Rema M, Mohan V, Deepa R. et al .
Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2).
Diabetes Care.
2004;
27
1962-1967
-
27
Ruderman NB, Haudenschild C.
Diabetes as an atherogenic factor.
Prog Cardiovasc Dis.
1984;
26
((5))
373-412
-
28
Safar ME, Levy BI, Struijker-Boudier H.
Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases.
Circulation.
2003;
107
((22))
2864-2869
-
29
Schram MT, Chaturvedi N, Schalkwijk CG. et al .
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes – the EURODIAB Prospective Complications Study.
Diabetologia.
2005;
48
((2))
370-378
-
30
Soedamah-Muthu SS, Chaturvedi N, Toeller M. et al .
Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
Diabetes Care.
2004;
27
((2))
530-537
-
31
van Hecke MV, Dekker JM, Stehouwer CD. et al .
Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study.
Diabetes Care.
2005;
28
((6))
1383-1389
-
32
Wakabayashi I, Masuda H.
Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus.
Clin Chim Acta.
2006;
365
((1–2))
230-235
-
33
Wellen KE, Hotamisligil GS.
Inflammation, stress, and diabetes.
J Clin Invest.
2005;
115
((5))
1111-1119
-
34
Wilkinson IB, MacCallum H, Rooijmans DF. et al .
Increased augmentation index and systolic stress in type 1 diabetes mellitus.
QJM.
2000;
93
((7))
441-448
-
35
Wykretowicz A, Adamska K, Guzik P. et al .
Indices of vascular stiffness and wave reflection in relation to body mass index or body fat in healthy subjects.
Clin Exp Pharmacol Physiol.
2007;
34
((10))
1005-1009
-
36
Wykretowicz A, Gerstenberger P, Guzik P. et al .
Arterial stiffness in relation to subclinical atherosclerosis.
Eur J Clin Invest.
2009;
39
((1))
11-16
Correspondence
A. Araszkiewicz
Department of Internal Medicine and Diabetology
Poznan University of Medical Sciences
Mickiewicza 2
60-834 Poznan
Poland
Phone: +48/61/847 4579
Fax: +48/61/847 4579
Email: olaaraszkiewicz@interia.pl
